학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 15건 | 목록 1~20
Academic Journal
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING; AUG 2018, 17 p20-p21, 2p. Supplement: 1
Academic Journal
Goodman J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, UK.; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Parker VE; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; McEniery CM; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, UK.; Di Stefano G; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Hubsch A; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Vamvaka E; Clinical Project Management, Vendor Partnerships, IQVIA, Reading, UK.; Helmy J; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Kaloyirou F; NHS Blood and Transplant, Clinical Trials Unit, Cambridge, UK.; Jalaludeen N; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Barker P; NIHR Cambridge BRC Core Biochemical Assay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Jermutus L; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Cheriyan J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, UK.; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Cardiovascular Trials Office, Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Ambery P; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wilkinson IB; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, UK.; Clinical Pharmacology Department, Cambridge University Hospitals NHS Foundation Trust, UK.; Cardiovascular Trials Office, Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Zhao TX; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Sriranjan RS; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Tuong ZK; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Hinxton, United Kingdom.; Lu Y; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Sage AP; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Nus M; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Hubsch A; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Kaloyirou F; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Vamvaka E; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Helmy J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Kostapanos M; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Jalaludeen N; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Klatzmann D; Department of Inflammation, Immunopathology, and Biotherapy, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Tedgui A; Paris Cardiovascular Research Center, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France.; Rudd JHF; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Horton SJ; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom.; Huntly BJP; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom.; Hoole SP; Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.; Bond SP; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Clatworthy MR; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Hinxton, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Cheriyan J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Mallat Z; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Paris Cardiovascular Research Center, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France.
Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Kaloyirou F
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어